Applying the Science Behind Parenteral Drug Stability for use in Assigning Beyond-Use Dates to Compounded Sterile Preparations - On Demand
Recorded On: 09/20/2023
-
Register
- Prices available after logging in
When manufacturer product labeling provides limited or no guidance on usage timeframes, published stability studies can help justify extending the beyond-use date (BUD) of a compounded sterile preparation (CSP). This presentation, tailored for pharmacists, pharmacy technicians, nurses, and dietitians, will focus on evaluating stability studies of parenteral drugs as a vital step in determining an appropriate BUD for CSPs.
Learning Objectives:
- Navigate the literature resources and review drug stability studies for validity.
- Assess the applicability of a drug stability study to assigning a beyond-use date to a compounded sterile preparation.
- Differentiate the changes made in USP <797>, analyze how these impact the beyond-use date.
Michelle Simpson, PharmD, BCSCP, MWC
Clinical Program Manager
National Home Infusion Association
Michelle C. Simpson, PharmD, BCSCP, MWC, is a Board Certified Sterile Compounding Pharmacist with an established career in home infusion. She is the Clinical Program Manager for the National Home Infusion Association (NHIA), where she is responsible for research studies, non-profit foundation initiatives, data benchmarking, and clinical education development. Michelle is Editor in Chief of Infusion Journal, a peer-reviewed scholarly publication that features independent original research on infusion therapies and is published by the National Home Infusion Foundation (NHIF). Michelle is Co-Editor of Extended Stability for Parenteral Drugs, 7th Edition, a publication of the American Society of Health-System Pharmacists (ASHP).
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Michelle Simpson has no relevant financial relationships with ineligible companies to disclose.
Christpher Roy, PharmD, BCSCP
Pharmacist Training Specialist
Option Care Health
Chris Roy, PharmD, BCSCP, began his career with Option Care Health in 2018 as a PGY-1 resident. Since that point, he has held roles as a Clinical Pharmacist, Pharmacy Supervisor, and currently is the Pharmacist Training Specialist with Option Care Health. Chris believes that proper training and education are key to the future of the pharmacy profession and necessary to further the home infusion industry.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Christopher Roy has no relevant financial relationships with ineligible companies to disclose.